((自动化翻译由路透提供，请见免责声明 ))
9月12日 - ** 莫德纳 盘前下跌 7.4% 至 73.65 美元
** 疫苗生产商预计 (link) 25财年销售额为25亿-35亿美元，低于分析师预计的37.4亿美元 - LSEG
** 预计 2026-2028 年的年复合增长率将超过 25%，主要得益于新产品的推出
** 上个月，该公司预计 24 财年的销售额为 30 亿至 35 亿美元，这是自 2020 年推出 COVID-19 疫苗以来的最低年销售额。
** 首席财务官 James Mock 说，25 财年的预测反映了美国 COVID 和呼吸道合胞病毒市场的不确定性。
** 补充说，公司已将其预测考虑在内，即到 2027 年获批的 10 种新产品将于 2028 年开始产生有意义的收入。
** 截至上一交易日收盘，股价累计下跌 20
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.